EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The methylation signature of hepatocellular carcinoma trajectory based on pseudotime and chronological time for predicting precancerous patients

Kang Li iD, Chaoran Zang, Yanan Zhao, Dandan Guo, Wanting Shi, Tingting Mei, Ang Li, Yonghong Zhang

The Oncologist · 2025

DOI: 10.1093/oncolo/oyae292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Kang Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Information Center, Beijing You'An Hospital, Capital Medical University; Beijing 100069, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, DNA Methylation, Precancerous Conditions. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Hospitals Authority Youth Programme, Beijing Research Center for Respiratory Infectious Diseases project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early screening of hepatocellular carcinoma (HCC) is strongly recommended for hepatitis B virus (HBV)-infected patients. We aimed to develop and validate a predictive nomogram based on HCC occurrence trajectory for screening precancerous patients with HCC.

Methods

Peripheral blood mononuclear cells (PBMC) samples from 22 patients with HCC with their precancerous stage (n = 55) and 18 healthy controls were measured using HumanMethylation EPIC BeadChip assay. HCC trajectory was assessed by pseudotime based on TimeAx algorithm and chronological time. The 43 candidate CpG sites were selected from the methylation signature and measured using multiplex bisulfite sequencing in a retrospective cohort of HBV-infected patients (n = 604). A 5-CpG-classifier was built using the LASSO Cox regression model, based on the association between the methylation level of every CpG and the duration from enrollment to HCC occurrence of individual patient. We validated the risk stratification and predictive accuracy of this classifier in both the primary cohort (n = 300) and independent validation cohort (n = 304).

Results

Pseudotime and chronological time of HCC trajectory analysis revealed that the PD-1/PD-L1 pathway underwent changes in the precancerous stage. Based on the trajectory of methylation signature, we built a 5-CpG-classifier which remained powerful and independent predictive efficiency after stratified analysis by clinicopathological risk factors in both primary cohort and independent validation cohort. A predicting nomogram including the 5-CpG-classifier was constructed after multivariate analysis. One-year cumulative hazard of HCC in low- and high-risk groups of HBV-infected patients was 3.0% (0.1%-5.8%) and 17.90% (11.00%-24.3%) (P < .0001) in primary cohort, 4.5% (1.20%-7.80%) and 27.3 (18.90-34.90) (P < .0001) in the independent validation cohort.

Conclusions

One-year before HCC was a critical period of transitional time when parts of the methylation profile underwent shifting toward HCC like. The nomogram could identify precancerous stage patients with HCC who should be screened for early diagnosis and intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsDNA MethylationPrecancerous ConditionsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedNomogramsCpG IslandsAdult

Stichwörter der Autor:innen

hepatocellular carcinoma trajectorymethylationprecancerous patientspredictive nomogram

Autor:innen und Institutionen

  • Biomedical Information Center, Beijing You'An Hospital, Capital Medical University; Beijing 100069, People's Republic of China.
  • Beijing Key Laboratory (BZ0373), Beijing You'An Hospital, Capital Medical University, Beijing 100069, People's Republic of China.
  • Beijing Research Center for Respiratory Infectious Diseases, Beijing 100013, People's Republic of China.
  • Interventional Therapy Center for Oncology, Beijing You'An Hospital, Capital Medical University, Beijing 100069, People's Republic of China.
  • Hepatobiliary Pancreatic Center Department, Beijing Tsinghua Changgung Hospital Affiliated to Tsinghua University, Beijing 102218, People's Republic of China.
  • Department of Minimal-Invasive Intervention, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, People's Republic of China.

ORCID-Profile: Kang Li

Förderung

  • Beijing Hospitals Authority Youth Programme
  • Beijing Research Center for Respiratory Infectious Diseases project

Zitieren

APA

Li, K., Zang, C., Zhao, Y., Guo, D., Shi, W., Mei, T., Li, A., & Zhang, Y. (2025). The methylation signature of hepatocellular carcinoma trajectory based on pseudotime and chronological time for predicting precancerous patients. The Oncologist. https://doi.org/10.1093/oncolo/oyae292

Vancouver

Li K, Zang C, Zhao Y, Guo D, Shi W, Mei T, et al. The methylation signature of hepatocellular carcinoma trajectory based on pseudotime and chronological time for predicting precancerous patients. The Oncologist. 2025. doi:10.1093/oncolo/oyae292

BibTeX
@article{Li2025,
  author = {Li, Kang and Zang, Chaoran and Zhao, Yanan and Guo, Dandan and Shi, Wanting and Mei, Tingting and Li, Ang and Zhang, Yonghong},
  title = {The methylation signature of hepatocellular carcinoma trajectory based on pseudotime and chronological time for predicting precancerous patients},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyae292}
}
Kostenlos starten →